David Thomson
Consejero General en MANNKIND CORPORATION .
Fortuna: 4 M $ al 31/05/2024
Cargos activos de David Thomson
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| MANNKIND CORPORATION | Consejero General | 01/01/2002 | - |
| Secretario Corporativo | 01/01/2002 | - | |
QrumPharma, Inc.
 QrumPharma, Inc. Pharmaceuticals: MajorHealth Technology QrumPharma, Inc. is engaged in developing drug products. It develops inhalation treatments for severe chronic and recurrent pulmonary infections, including Nontuberculous Mycobacterial (NTM) lung disease. The company was founded by Thomas Hofmann and is headquartered in Doylestown, PA. | Corporate Officer/Principal | - | - |
Historial de carrera de David Thomson
Formación de David Thomson.
| Queen's University | Doctorate Degree |
| University of Toronto | Graduate Degree |
Estadísticas
Internacional
| Estados Unidos | 3 |
| Canadá | 3 |
Operativa
| Graduate Degree | 2 |
| General Counsel | 1 |
| Corporate Secretary | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| MANNKIND CORPORATION | Health Technology |
| Empresas privadas | 1 |
|---|---|
QrumPharma, Inc.
QrumPharma, Inc. Pharmaceuticals: MajorHealth Technology QrumPharma, Inc. is engaged in developing drug products. It develops inhalation treatments for severe chronic and recurrent pulmonary infections, including Nontuberculous Mycobacterial (NTM) lung disease. The company was founded by Thomas Hofmann and is headquartered in Doylestown, PA. | Health Technology |
- Bolsa de valores
- Insiders
- David Thomson
- Experiencia
